Steric bulk

Steric bulk refers to the three-dimensional size of a group of atoms — how much space it occupies and how much it crowds or shields the area immediately around it.

The concept originates in physical organic chemistry, where larger substituents were found to slow or block nearby reactions through pure spatial interference, with no electronic effect required. In drug design, it becomes a lever: a bulky group added to a molecule can shield a cleavable bond from enzyme access, alter how tightly and selectively the compound fits a receptor pocket, and slow the metabolic enzymes that would otherwise break it down.

For the purposes of this encyclopedia, steric bulk comes up most often in discussions of prodrugs and receptor selectivity — two properties that directly shape what a substance does and how long it takes to do it.

How it works · its role

Enzymes are physical machines. To break a bond, an enzyme must position its active site around that bond with considerable geometric precision. A large substituent nearby forces the enzyme to approach from a narrower angle, or not at all — the bulkier the shielding group, the slower the cleavage, and in some cases the conversion does not occur at meaningful rates.

The same principle governs receptor binding. A binding pocket has a defined three-dimensional shape; a substituent too large to fit blocks docking entirely, while one that fits snugly can act as a selectivity filter — locking the compound into one receptor subtype over another that differs only in the dimensions of its cleft.

Cytochrome P450 enzymes in the liver are similarly sensitive to steric crowding. Molecules with bulky substituents shielding the site the enzyme would otherwise oxidise are broken down more slowly, which typically extends their effective duration.

Relevance to substances & effects

Prodrug strategies across several well-known psychoactive substance classes exploit this property deliberately.

Psilocybin is psilocin with a phosphate group attached. That group is both polar and moderately bulky, limiting direct CNS penetration; alkaline phosphatases in the gut mucosa and liver cleave it, releasing psilocin. The conversion rate — and thus the onset curve — reflects in part how readily those enzymes can access the bond. 4-AcO-DMT, an acetate ester of psilocin, works analogously: esterases cleave the acetate, again with kinetics shaped by how much the ester group obstructs enzyme approach.

Steric bulk also helps explain divergent profiles within substance classes. In the ergoline family, LSD's bulky diethylamide group contributes to its high receptor affinity and resistance to rapid hepatic metabolism — part of the structural reason its effects persist at doses far smaller than most other psychedelics. Within the benzodiazepine family, substituent size at specific ring positions influences which GABA-A subunit combinations a compound favours, shifting the balance between sedation, anxiety suppression, and muscle relaxation.

When a substance page describes two structurally related compounds with markedly different onset times, durations, or effect profiles, a difference in steric bulk around a cleavable bond or a metabolic site is often the underlying structural reason.